According to the SEC Form 4 filings, Bredt David, being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $1,141,345 | 5 | 100 |
| 2026-02-17 | Sale | Rapport Therapeutics, Inc. Common Stock RAPP | Chief Scientific Officer | 8,500 0.0233% | $29.02 | $246,655 | +26.72% | |
| 2026-01-15 | Sale | Rapport Therapeutics, Inc. Common Stock RAPP | Chief Scientific Officer | 8,500 0.0233% | $26.84 | $228,132 | +32.5% | |
| 2025-12-31 | Sale | Rapport Therapeutics, Inc. Common Stock RAPP | Chief Scientific Officer | 6,567 0.0179% | $30.05 | $197,338 | +15.95% | |
| 2025-12-15 | Sale | Rapport Therapeutics, Inc. Common Stock RAPP | Chief Scientific Officer | 8,500 0.0232% | $30.02 | $255,130 | +15.37% | |
| 2025-11-17 | Sale | Rapport Therapeutics, Inc. Common Stock RAPP | Chief Scientific Officer | 8,500 0.0195% | $25.19 | $214,091 | +33.17% | |
| 2025-10-15 | Sale | Rapport Therapeutics, Inc. Common Stock RAPP | Chief Scientific Officer | 8,500 0.0199% | $25.79 | $219,196 | +25.6% | |
| 2025-09-15 | Sale | Rapport Therapeutics, Inc. Common Stock RAPP | Chief Scientific Officer | 8,500 0.0187% | $24.19 | $205,649 | +22.4% | |
| 2025-08-15 | Sale | Rapport Therapeutics, Inc. Common Stock RAPP | Chief Scientific Officer | 8,500 0.0116% | $15.00 | $127,466 | +98.98% | |
| 2025-07-15 | Sale | Rapport Therapeutics, Inc. Common Stock RAPP | Chief Scientific Officer | 8,500 0.0108% | $14.00 | $118,962 | +96.87% | |
| 2025-06-16 | Sale | Rapport Therapeutics, Inc. Common Stock RAPP | Chief Scientific Officer | 8,500 0.0085% | $11.00 | $93,522 | +146.79% | |
| 2025-05-15 | Sale | Rapport Therapeutics, Inc. Common Stock RAPP | Chief Scientific Officer | 8,500 0.0074% | $9.56 | $81,262 | +175.41% | |
| 2025-04-15 | Sale | Rapport Therapeutics, Inc. Common Stock RAPP | Chief Scientific Officer | 8,500 0.0074% | $9.57 | $81,310 | +173.39% | |
| 2025-03-14 | Sale | Rapport Therapeutics, Inc. Common Stock RAPP | Chief Scientific Officer | 8,500 0.0084% | $10.85 | $92,205 | +135.01% |